CD47 and ovarian carcinoma: These results suggest that CD47 expression level was quite different in distinct cell types with the highest in malignant ovarian cancer cells and the cell components of primary and metastatic patients are different, which might be the source of ovarian cancer microenvironment heterogeneity.